Inventor · disambiguated record
Jeffrey Shabanowitz
Also filed as: SHABANOWITZ JEFFREY
14 granted patents·15 pending applications·82 citations·filing 1977–2022
90Inventor score
Files withUNIV VIRGINIA PATENT FOUNDATION11AGENUS INC5HUNT DONALD F2UNIV VIRGINIA2VIRGINIA UNIVERSITY2
Top patents by PatentIndex Score
29 records- 0183US4175234AApparatus for producing ions of thermally labile or nonvolatile solidsVIRGINIA UNIVERSITY·Filed 1978·Granted Nov 20, 1979·21 cites·16 claims
- 0277US8119984B2Method and apparatus for generation of reagent ions in a mass spectrometerSHABANOWITZ JEFFREY·Filed 2009·Granted Feb 21, 2012·7 cites·29 claims
- 0376US9561266B2Target peptides for immunotherapy and diagnosticsU VA LICENSING & VENTURES GROUP·Filed 2013·Granted Feb 7, 2017·5 cites·18 claims
- 0472US10682399B2Target peptides for colorectal cancer therapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2013·Granted Jun 16, 2020·2 cites·101 claims
- 0571US12347665B2Rapid identification and sequence analysis of intact proteins in complex mixturesUNIV VIRGINIA PATENT FOUNDATION·Filed 2022·Granted Jul 1, 2025·0 cites·11 claims
- 0671US12042530B2Target peptides for immunotherapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Granted Jul 23, 2024·0 cites·7 claims
- 0771US10640535B2Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategiesAGENUS INC·Filed 2013·Granted May 5, 2020·2 cites·55 claims
- 0871US2023059301A1Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategiesAGENUS INC·Filed 2022·Application pending·0 cites
- 0967US4156814AApparatus for producing ions of thermally labile or nonvolatile solidsVIRGINIA UNIVERSITY·Filed 1977·Granted May 29, 1979·11 cites·8 claims
- 1067US2022041655A1Class i mhc phosphopeptides for cancer immunotherapy and diagnosisAGENUS INC·Filed 2021·Application pending·0 cites
- 1160US11414458B2Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategiesAGENUS INC·Filed 2020·Granted Aug 16, 2022·0 cites·9 claims
- 1260US2021154279A1Target peptides for colorectal cancer therapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 1360US2022211828A1Target peptides for ovarian cancer therapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Application pending·0 cites
- 1459US2016000893A1Target peptides for ovarian cancer therapy and diagnosticsUniv Virginia Patent Found·Filed 2013·Application pending·0 cites
- 1558US6660276B1Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses thereforUNIV VIRGINIA·Filed 1994·Granted Dec 9, 2003·21 cites·12 claims
- 1657US7019112B1Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses thereforUNIV VIRGINIA·Filed 1997·Granted Mar 28, 2006·12 cites·5 claims
- 1752US2023176069A1Mitigating concentration effects of antibody digestion for complete sequence coverageUNIV VIRGINIA PATENT FOUNDATION·Filed 2021·Application pending·0 cites
- 1850US2018066017A1Class i mhc phosphopeptides for cancer immunotherapy and diagnosisAGENUS INC·Filed 2017·Application pending·0 cites
- 1949US8758767B2Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereofDILORENZO TERESA P·Filed 2004·Granted Jun 24, 2014·1 cites·3 claims
- 2048US2022265791A1Target peptides for cancer therapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 2148US2017333541A1Target peptides for immunotherapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2016·Application pending·0 cites
- 2247US2013259883A1Class i mhc phosphopeptides for cancer immunotherapy and diagnosisHUNT DONALD F·Filed 2011·Application pending·0 cites
- 2347US2022387567A1Compositions and methods for treating diseases and disorders associated with aberrant regulation of proteinsUNIV VIRGINIA PATENT FOUNDATION·Filed 2020·Application pending·0 cites
- 2446US11538675B2Rapid identification and sequence analysis of intact proteins in complex mixturesHUNT DONALD F·Filed 2017·Granted Dec 27, 2022·0 cites·3 claims
- 2543US2003211116A1Mhc peptides over-expressed on prostate cancer cells and methods of useFiled 2001·Application pending·0 cites
- 2638US2019015494A1Identification of class i mhc associated glycopeptides as targets for cancer immunotherapyUNIV VIRGINIA PATENT FOUNDATION·Filed 2016·Application pending·0 cites
- 2738US2005277161A1Phosphopeptide antigens associated with MHC moleculesENGELHARD VICTOR H·Filed 2005·Application pending·0 cites
- 2837US2019374627A1Target peptides for cancer therapy and diagnosticsUNIV VIRGINIA PATENT FOUNDATION·Filed 2017·Application pending·0 cites
- 2936US9279011B2Phosphopeptides as melanoma vaccinesTOPALIAN SUZANNE L·Filed 2010·Granted Mar 8, 2016·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Jeffrey Shabanowitz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →